According to Latest Study, the global market for Anti-erectile Dysfunction (ED) Drugs should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.
China Anti-erectile Dysfunction (ED) Drugs market should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.
The United States Anti-erectile Dysfunction (ED) Drugs market should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.
In terms of type, Sildenafil (Viagra) segment holds a share about % in 2024 and will reach % in 2030; while in terms of application, Hospital has a share approximately % in 2023 and will grow at a CAGR % during 2024 and 2030.
The global key manufacturers of Anti-erectile Dysfunction (ED) Drugs include Vivus, Inc., Lilly ICOS LLC, Pfizer, Bayer, Hims, Menarini Group, Lupin, Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd and General Factory, etc. In 2022, the global top five players hold a share approximately % in terms of revenue.
This report aims to provide a comprehensive study of the global market for Anti-erectile Dysfunction (ED) Drugs. Report Highlights:
(1) Global Anti-erectile Dysfunction (ED) Drugs market size (sales volume & revenue), history data from 2019-2023 and forecast data from 2024 to 2030.
(2) Global Anti-erectile Dysfunction (ED) Drugs market competitive situation, sales, revenue, price and market share, from 2019 to 2023.
(3) China Anti-erectile Dysfunction (ED) Drugs market competitive situation, sales, revenue, price and market share, from 2019 to 2023.
(4) Global Anti-erectile Dysfunction (ED) Drugs segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.
(5) Global Anti-erectile Dysfunction (ED) Drugs segment by type and by application and regional segment by type and by application.
(6) Global major production regions of Anti-erectile Dysfunction (ED) Drugs, capacity, production and trends.
(7) Anti-erectile Dysfunction (ED) Drugs industry supply chain, upstream, midstream and downstream analysis.
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Market segment by type, covers
Sildenafil (Viagra)
Vardenafil (Levitra, Staxyn)
Tadalafil (Cialis)
Avanafil (Stendra)
Udenafil (Zydena)
Others
Market segment by application, can be divided into
Hospital
Retail Pharmacy
Clinic
Online Pharmacy
Market segment by players, this report covers
Vivus, Inc.
Lilly ICOS LLC
Pfizer
Bayer
Hims
Menarini Group
Lupin
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
General Factory
CSBio
Dong-A ST
Metuchen Pharma
Seoul Pharma
Teva Pharma
S.K. Chemicals
1 Market Overview
1.1 Anti-erectile Dysfunction (ED) Drugs Definition
1.2 Global Anti-erectile Dysfunction (ED) Drugs Market Size and Forecast
1.2.1 By Revenue, Global Anti-erectile Dysfunction (ED) Drugs Market Size, 2019-2030
1.2.2 By Sales Volume, Global Anti-erectile Dysfunction (ED) Drugs Market Size, 2019-2030
1.2.3 Global Anti-erectile Dysfunction (ED) Drugs Price Trend, 2019-2030
1.3 China Anti-erectile Dysfunction (ED) Drugs Market Size and Forecast
1.3.1 By Revenue, China Anti-erectile Dysfunction (ED) Drugs Market Size, 2019-2030
1.3.2 By Sales Volume, China Anti-erectile Dysfunction (ED) Drugs Market Size, 2019-2030
1.3.3 China Anti-erectile Dysfunction (ED) Drugs Price Trend, 2019-2030
1.4 China Percentage in Global Market
1.4.1 By Revenue, China Anti-erectile Dysfunction (ED) Drugs Share in Global Market, 2019-2030
1.4.2 By Sales Volume, China Anti-erectile Dysfunction (ED) Drugs Share in Global Market, 2019-2030
1.4.3 Anti-erectile Dysfunction (ED) Drugs Market Size: China VS Global, 2019-2030
1.5 Anti-erectile Dysfunction (ED) Drugs Market Dynamics
1.5.1 Anti-erectile Dysfunction (ED) Drugs Market Drivers
1.5.2 Anti-erectile Dysfunction (ED) Drugs Market Restraints
1.5.3 Anti-erectile Dysfunction (ED) Drugs Industry Trends
1.5.4 Anti-erectile Dysfunction (ED) Drugs Industry Policy
2 Global Competitive Landscape by Company
2.1 Global Anti-erectile Dysfunction (ED) Drugs Revenue by Company, 2019-2024
2.2 Global Anti-erectile Dysfunction (ED) Drugs Sales Volume by Company, 2019-2024
2.3 Global Anti-erectile Dysfunction (ED) Drugs Price by Company, 2019-2024
2.4 Global Anti-erectile Dysfunction (ED) Drugs Participants, Market Position (Tier 1, Tier 2 and Tier 3)
2.5 Global Anti-erectile Dysfunction (ED) Drugs Concentration Ratio
2.6 Global Anti-erectile Dysfunction (ED) Drugs Mergers & Acquisitions, Expansion Plans
2.7 Global Anti-erectile Dysfunction (ED) Drugs Manufacturers Product Type
3 China Competitive Landscape by Company
3.1 China Anti-erectile Dysfunction (ED) Drugs Revenue by Company, 2019-2024
3.2 China Anti-erectile Dysfunction (ED) Drugs Sales Volume by Company, 2019-2024
3.3 China Anti-erectile Dysfunction (ED) Drugs Anti-erectile Dysfunction (ED) Drugs Participants, Market Position (Tier 1, Tier 2 and Tier 3)
3.4 China Anti-erectile Dysfunction (ED) Drugs Market, Sales Percentage of Local Players VS Foreign Players (2019-2024)
3.5 Chinese Local Players, Anti-erectile Dysfunction (ED) Drugs Domestic VS Export
3.6 China Market, Anti-erectile Dysfunction (ED) Drugs Import & Export
3.6.1 China Market, Anti-erectile Dysfunction (ED) Drugs Import & Export, 2019-2030
3.6.2 China Anti-erectile Dysfunction (ED) Drugs Import & Export Trends
3.6.3 Main Sources of China Anti-erectile Dysfunction (ED) Drugs Import
3.6.4 Export Destination of China Anti-erectile Dysfunction (ED) Drugs
4 Anti-erectile Dysfunction (ED) Drugs Production by Region
4.1 Global Anti-erectile Dysfunction (ED) Drugs Capacity, Production and Capacity Utilization, 2019-2030
4.2 Global Geographic Distribution of Anti-erectile Dysfunction (ED) Drugs Manufacturers
4.3 Global Major Manufacturers, Anti-erectile Dysfunction (ED) Drugs Capacity Expansion and Future Plans
4.4 Global Anti-erectile Dysfunction (ED) Drugs Capacity by Region
4.5 Global Anti-erectile Dysfunction (ED) Drugs Production by Region
4.5.1 Global Anti-erectile Dysfunction (ED) Drugs Production & Forecast by Region, 2019 VS 2024 VS 2030
4.5.2 Global Anti-erectile Dysfunction (ED) Drugs Production by Region, 2019-2024
4.5.3 Global Anti-erectile Dysfunction (ED) Drugs Production Market Share & Forecast by Region, 2019-2030
5 Industry Chain Analysis
5.1 Anti-erectile Dysfunction (ED) Drugs Industry Chain
5.2 Anti-erectile Dysfunction (ED) Drugs Upstream Analysis
5.2.1 Anti-erectile Dysfunction (ED) Drugs Core Raw Materials
5.2.2 Main Manufacturers of Anti-erectile Dysfunction (ED) Drugs Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Anti-erectile Dysfunction (ED) Drugs Production Mode
5.6 Anti-erectile Dysfunction (ED) Drugs Procurement Model
5.7 Anti-erectile Dysfunction (ED) Drugs Industry Sales Model and Sales Channels
5.7.1 Anti-erectile Dysfunction (ED) Drugs Sales Model
5.7.2 Anti-erectile Dysfunction (ED) Drugs Typical Distributors
6 Sights by Type
6.1 Anti-erectile Dysfunction (ED) Drugs Classification
6.1.1 Sildenafil (Viagra)
6.1.2 Vardenafil (Levitra, Staxyn)
6.1.3 Tadalafil (Cialis)
6.1.4 Avanafil (Stendra)
6.1.5 Udenafil (Zydena)
6.1.6 Others
6.2 By Type, Global Anti-erectile Dysfunction (ED) Drugs Market Size & CAGR, 2019 VS 2024 VS 2030
6.3 By Type, Global Anti-erectile Dysfunction (ED) Drugs Revenue, 2019-2030
6.4 By Type, Global Anti-erectile Dysfunction (ED) Drugs Sales Volume, 2019-2030
6.5 By Type, Global Anti-erectile Dysfunction (ED) Drugs Price, 2019-2030
7 Sights by Application
7.1 Anti-erectile Dysfunction (ED) Drugs Segment by Application
7.1.1 Hospital
7.1.2 Retail Pharmacy
7.1.3 Clinic
7.1.4 Online Pharmacy
7.2 By Application, Global Anti-erectile Dysfunction (ED) Drugs Market Size & CAGR, 2019 VS 2024 VS 2030
7.3 By Application, Global Anti-erectile Dysfunction (ED) Drugs Revenue, 2019-2030
7.4 By Application, Global Anti-erectile Dysfunction (ED) Drugs Sales Volume, 2019-2030
7.5 By Application, Global Anti-erectile Dysfunction (ED) Drugs Price, 2019-2030
8 Sales Sights by Region
8.1 By Region, Global Anti-erectile Dysfunction (ED) Drugs Market Size, 2019 VS 2024 VS 2030
8.2 By Region, Global Anti-erectile Dysfunction (ED) Drugs Revenue, 2019-2030
8.3 By Region, Global Anti-erectile Dysfunction (ED) Drugs Sales Volume, 2019-2030
8.4 North America
8.4.1 North America Anti-erectile Dysfunction (ED) Drugs Market Size & Forecasts, 2019-2030
8.4.2 By Country, North America Anti-erectile Dysfunction (ED) Drugs Market Size Market Share
8.5 Europe
8.5.1 Europe Anti-erectile Dysfunction (ED) Drugs Market Size & Forecasts, 2019-2030
8.5.2 By Country, Europe Anti-erectile Dysfunction (ED) Drugs Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific Anti-erectile Dysfunction (ED) Drugs Market Size & Forecasts, 2019-2030
8.6.2 By Country/Region, Asia Pacific Anti-erectile Dysfunction (ED) Drugs Market Size Market Share
8.7 South America
8.7.1 South America Anti-erectile Dysfunction (ED) Drugs Market Size & Forecasts, 2019-2030
8.7.2 By Country, South America Anti-erectile Dysfunction (ED) Drugs Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level
9.1 By Country, Global Anti-erectile Dysfunction (ED) Drugs Market Size & CAGR,2019 VS 2024 VS 2030
9.2 By Country, Global Anti-erectile Dysfunction (ED) Drugs Revenue, 2019-2030
9.3 By Country, Global Anti-erectile Dysfunction (ED) Drugs Sales Volume, 2019-2030
9.4 U.S.
9.4.1 U.S. Anti-erectile Dysfunction (ED) Drugs Market Size, 2019-2030
9.4.2 By Company, U.S. Anti-erectile Dysfunction (ED) Drugs Sales Volume Market Share, 2022
9.4.3 By Type, U.S. Anti-erectile Dysfunction (ED) Drugs Market Size, Share, 2022 VS 2029
9.4.4 By Application, U.S. Anti-erectile Dysfunction (ED) Drugs Market Size, Share, 2022 VS 2029
9.5 Europe
9.5.1 Europe Anti-erectile Dysfunction (ED) Drugs Market Size, 2019-2030
9.5.2 By Company, Europe Anti-erectile Dysfunction (ED) Drugs Sales Volume Market Share, 2022
9.5.3 By Type, Europe Anti-erectile Dysfunction (ED) Drugs Market Size, Share, 2022 VS 2029
9.5.4 By Application, Europe Anti-erectile Dysfunction (ED) Drugs Market Size, Share, 2022 VS 2029
9.6 China
9.6.1 China Anti-erectile Dysfunction (ED) Drugs Market Size, 2019-2030
9.6.2 By Company, China Anti-erectile Dysfunction (ED) Drugs Sales Volume Market Share, 2022
9.6.3 By Type, China Anti-erectile Dysfunction (ED) Drugs Market Size, Share, 2022 VS 2029
9.6.4 By Application, China Anti-erectile Dysfunction (ED) Drugs Market Size, Share, 2022 VS 2029
9.7 Japan
9.7.1 Japan Anti-erectile Dysfunction (ED) Drugs Market Size, 2019-2030
9.7.2 By Company, Japan Anti-erectile Dysfunction (ED) Drugs Sales Volume Market Share, 2022
9.7.3 By Type, Japan Anti-erectile Dysfunction (ED) Drugs Market Size, Share, 2022 VS 2029
9.7.4 By Application, Japan Anti-erectile Dysfunction (ED) Drugs Market Size, Share, 2022 VS 2029
9.8 South Korea
9.8.1 South Korea Anti-erectile Dysfunction (ED) Drugs Market Size, 2019-2030
9.8.2 By Company, South Korea Anti-erectile Dysfunction (ED) Drugs Sales Volume Market Share, 2022
9.8.3 By Type, South Korea Anti-erectile Dysfunction (ED) Drugs Market Size, Share, 2022 VS 2029
9.8.4 By Application, South Korea Anti-erectile Dysfunction (ED) Drugs Market Size, Share, 2022 VS 2029
9.9 Southeast Asia
9.9.1 Southeast Asia Anti-erectile Dysfunction (ED) Drugs Market Size, 2019-2030
9.9.2 By Company, Southeast Asia Anti-erectile Dysfunction (ED) Drugs Sales Volume Market Share, 2022
9.9.3 By Type, Southeast Asia Anti-erectile Dysfunction (ED) Drugs Market Size, Share, 2022 VS 2029
9.9.4 By Application, Southeast Asia Anti-erectile Dysfunction (ED) Drugs Market Size, Share, 2022 VS 2029
9.10 India
9.10.1 India Anti-erectile Dysfunction (ED) Drugs Market Size, 2019-2030
9.10.2 By Company, India Anti-erectile Dysfunction (ED) Drugs Sales Volume Market Share, 2022
9.10.3 By Type, India Anti-erectile Dysfunction (ED) Drugs Market Size, Share, 2022 VS 2029
9.10.4 By Application, India Anti-erectile Dysfunction (ED) Drugs Market Size, Share, 2022 VS 2029
9.11 Middle East & Asia
9.11.1 Middle East & Asia Anti-erectile Dysfunction (ED) Drugs Market Size, 2019-2030
9.11.2 By Company, Middle East & Asia Anti-erectile Dysfunction (ED) Drugs Sales Volume Market Share, 2022
9.11.3 By Type, Middle East & Asia Anti-erectile Dysfunction (ED) Drugs Market Size, Share, 2022 VS 2029
9.11.4 By Application, Middle East & Asia Anti-erectile Dysfunction (ED) Drugs Market Size, Share, 2022 VS 2029
10 Manufacturers Profile
10.1 Vivus, Inc.
10.1.1 Vivus, Inc. Company Information, Head Office, Market Area and Industry Position
10.1.2 Vivus, Inc. Anti-erectile Dysfunction (ED) Drugs Models, Specifications and Application
10.1.3 Vivus, Inc. Anti-erectile Dysfunction (ED) Drugs Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.1.4 Vivus, Inc. Company Profile and Main Business
10.1.5 Vivus, Inc. Recent Developments
10.2 Lilly ICOS LLC
10.2.1 Lilly ICOS LLC Company Information, Head Office, Market Area and Industry Position
10.2.2 Lilly ICOS LLC Anti-erectile Dysfunction (ED) Drugs Models, Specifications and Application
10.2.3 Lilly ICOS LLC Anti-erectile Dysfunction (ED) Drugs Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.2.4 Lilly ICOS LLC Company Profile and Main Business
10.2.5 Lilly ICOS LLC Recent Developments
10.3 Pfizer
10.3.1 Pfizer Company Information, Head Office, Market Area and Industry Position
10.3.2 Pfizer Anti-erectile Dysfunction (ED) Drugs Models, Specifications and Application
10.3.3 Pfizer Anti-erectile Dysfunction (ED) Drugs Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.3.4 Pfizer Company Profile and Main Business
10.3.5 Pfizer Recent Developments
10.4 Bayer
10.4.1 Bayer Company Information, Head Office, Market Area and Industry Position
10.4.2 Bayer Anti-erectile Dysfunction (ED) Drugs Models, Specifications and Application
10.4.3 Bayer Anti-erectile Dysfunction (ED) Drugs Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.4.4 Bayer Company Profile and Main Business
10.4.5 Bayer Recent Developments
10.5 Hims
10.5.1 Hims Company Information, Head Office, Market Area and Industry Position
10.5.2 Hims Anti-erectile Dysfunction (ED) Drugs Models, Specifications and Application
10.5.3 Hims Anti-erectile Dysfunction (ED) Drugs Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.5.4 Hims Company Profile and Main Business
10.5.5 Hims Recent Developments
10.6 Menarini Group
10.6.1 Menarini Group Company Information, Head Office, Market Area and Industry Position
10.6.2 Menarini Group Anti-erectile Dysfunction (ED) Drugs Models, Specifications and Application
10.6.3 Menarini Group Anti-erectile Dysfunction (ED) Drugs Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.6.4 Menarini Group Company Profile and Main Business
10.6.5 Menarini Group Recent Developments
10.7 Lupin
10.7.1 Lupin Company Information, Head Office, Market Area and Industry Position
10.7.2 Lupin Anti-erectile Dysfunction (ED) Drugs Models, Specifications and Application
10.7.3 Lupin Anti-erectile Dysfunction (ED) Drugs Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.7.4 Lupin Company Profile and Main Business
10.7.5 Lupin Recent Developments
10.8 Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
10.8.1 Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Company Information, Head Office, Market Area and Industry Position
10.8.2 Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Anti-erectile Dysfunction (ED) Drugs Models, Specifications and Application
10.8.3 Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Anti-erectile Dysfunction (ED) Drugs Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.8.4 Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Company Profile and Main Business
10.8.5 Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Recent Developments
10.9 General Factory
10.9.1 General Factory Company Information, Head Office, Market Area and Industry Position
10.9.2 General Factory Anti-erectile Dysfunction (ED) Drugs Models, Specifications and Application
10.9.3 General Factory Anti-erectile Dysfunction (ED) Drugs Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.9.4 General Factory Company Profile and Main Business
10.9.5 General Factory Recent Developments
10.10 CSBio
10.10.1 CSBio Company Information, Head Office, Market Area and Industry Position
10.10.2 CSBio Anti-erectile Dysfunction (ED) Drugs Models, Specifications and Application
10.10.3 CSBio Anti-erectile Dysfunction (ED) Drugs Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.10.4 CSBio Company Profile and Main Business
10.10.5 CSBio Recent Developments
10.11 Dong-A ST
10.11.1 Dong-A ST Company Information, Head Office, Market Area and Industry Position
10.11.2 Dong-A ST Anti-erectile Dysfunction (ED) Drugs Models, Specifications and Application
10.11.3 Dong-A ST Anti-erectile Dysfunction (ED) Drugs Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.11.4 Dong-A ST Company Profile and Main Business
10.11.5 Dong-A ST Recent Developments
10.12 Metuchen Pharma
10.12.1 Metuchen Pharma Company Information, Head Office, Market Area and Industry Position
10.12.2 Metuchen Pharma Anti-erectile Dysfunction (ED) Drugs Models, Specifications and Application
10.12.3 Metuchen Pharma Anti-erectile Dysfunction (ED) Drugs Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.12.4 Metuchen Pharma Company Profile and Main Business
10.12.5 Metuchen Pharma Recent Developments
10.13 Seoul Pharma
10.13.1 Seoul Pharma Company Information, Head Office, Market Area and Industry Position
10.13.2 Seoul Pharma Anti-erectile Dysfunction (ED) Drugs Models, Specifications and Application
10.13.3 Seoul Pharma Anti-erectile Dysfunction (ED) Drugs Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.13.4 Seoul Pharma Company Profile and Main Business
10.13.5 Seoul Pharma Recent Developments
10.14 Teva Pharma
10.14.1 Teva Pharma Company Information, Head Office, Market Area and Industry Position
10.14.2 Teva Pharma Anti-erectile Dysfunction (ED) Drugs Models, Specifications and Application
10.14.3 Teva Pharma Anti-erectile Dysfunction (ED) Drugs Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.14.4 Teva Pharma Company Profile and Main Business
10.14.5 Teva Pharma Recent Developments
10.15 S.K. Chemicals
10.15.1 S.K. Chemicals Company Information, Head Office, Market Area and Industry Position
10.15.2 S.K. Chemicals Anti-erectile Dysfunction (ED) Drugs Models, Specifications and Application
10.15.3 S.K. Chemicals Anti-erectile Dysfunction (ED) Drugs Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.15.4 S.K. Chemicals Company Profile and Main Business
10.15.5 S.K. Chemicals Recent Developments
11 Conclusion
12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer
Table 1. Anti-erectile Dysfunction (ED) Drugs Market Size & CAGR: China VS Global, 2019-2030, US$ Million
Table 2. Anti-erectile Dysfunction (ED) Drugs Market Restraints
Table 3. Anti-erectile Dysfunction (ED) Drugs Market Trends
Table 4. Anti-erectile Dysfunction (ED) Drugs Industry Policy
Table 5. Global Anti-erectile Dysfunction (ED) Drugs Revenue by Company, 2019-2024, US$ million
Table 6. Global Anti-erectile Dysfunction (ED) Drugs Revenue Market Share by Company, 2019-2024
Table 7. Global Anti-erectile Dysfunction (ED) Drugs Sales Volume by Company, 2019-2024, (K Units)
Table 8. Global Anti-erectile Dysfunction (ED) Drugs Sales Volume Market Share by Company, 2019-2024
Table 9. Global Anti-erectile Dysfunction (ED) Drugs Price by Company, 2019-2024, (US$/Unit)
Table 10. Global Anti-erectile Dysfunction (ED) Drugs Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global Anti-erectile Dysfunction (ED) Drugs Mergers & Acquisitions, Expansion Plans
Table 12. Global Anti-erectile Dysfunction (ED) Drugs Manufacturers Product Type
Table 13. China Anti-erectile Dysfunction (ED) Drugs Revenue by Company, 2019-2024, US$ million
Table 14. China Anti-erectile Dysfunction (ED) Drugs Revenue Market Share by Company, 2019-2024
Table 15. China Anti-erectile Dysfunction (ED) Drugs Sales Volume by Company, 2019-2024, (K Units)
Table 16. China Anti-erectile Dysfunction (ED) Drugs Sales Volume Market Share by Company, 2019-2024
Table 17. China Market, Anti-erectile Dysfunction (ED) Drugs Production, Sales, Import and Export, 2019-2030, (K Units)
Table 18. China Anti-erectile Dysfunction (ED) Drugs Import & Export Trends
Table 19. Main Sources of China Anti-erectile Dysfunction (ED) Drugs Import
Table 20. Export Destination of China Anti-erectile Dysfunction (ED) Drugs
Table 21. Global Headquarters and Manufacturing Base of Anti-erectile Dysfunction (ED) Drugs Manufacturers
Table 22. Global Major Manufacturers, Anti-erectile Dysfunction (ED) Drugs Capacity Expansion and Future Plans
Table 23. Global Anti-erectile Dysfunction (ED) Drugs Production & Forecast by Region, 2019 VS 2024 VS 2030, (K Units)
Table 24. Global Anti-erectile Dysfunction (ED) Drugs Production by Region, 2019-2024, (K Units)
Table 25. Global Anti-erectile Dysfunction (ED) Drugs Production Forecast by Region, 2024-2030, (K Units)
Table 26. Global Key Players of Anti-erectile Dysfunction (ED) Drugs Upstream (Raw Materials)
Table 27. Global Anti-erectile Dysfunction (ED) Drugs Typical Customers
Table 28. Anti-erectile Dysfunction (ED) Drugs Typical Distributors
Table 29. By Type, Global Anti-erectile Dysfunction (ED) Drugs Revenue & CAGR, 2019 VS 2024 VS 2030, US$ Million
Table 30. By Application, Global Anti-erectile Dysfunction (ED) Drugs Revenue & CAGR, 2019 VS 2024 VS 2030, US$ Million
Table 31. By Region, Global Anti-erectile Dysfunction (ED) Drugs Market Size, 2019 VS 2024 VS 2030, US$ Million
Table 32. By Region, Global Anti-erectile Dysfunction (ED) Drugs Revenue, 2019-2030, US$ Million
Table 33. By Region, Global Anti-erectile Dysfunction (ED) Drugs Sales Volume, 2019-2030, (K Units)
Table 34. By Country, Global Anti-erectile Dysfunction (ED) Drugs Revenue & CAGR,2019 VS 2024 VS 2030, US$ Million
Table 35. By Country, Global Anti-erectile Dysfunction (ED) Drugs Revenue, 2019-2030, US$ Million
Table 36. By Country, Global Anti-erectile Dysfunction (ED) Drugs Revenue Market Share, 2019-2030
Table 37. By Country, Global Anti-erectile Dysfunction (ED) Drugs Sales Volume, 2019-2030, (K Units)
Table 38. By Country, Global Anti-erectile Dysfunction (ED) Drugs Sales Volume Market Share, 2019-2030
Table 39. Vivus, Inc. Company Information, Head Office, Market Area and Industry Position
Table 40. Vivus, Inc. Anti-erectile Dysfunction (ED) Drugs Models, Specifications and Application
Table 41. Vivus, Inc. Anti-erectile Dysfunction (ED) Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 42. Vivus, Inc. Company Profile and Main Business
Table 43. Vivus, Inc. Recent Developments
Table 44. Lilly ICOS LLC Company Information, Head Office, Market Area and Industry Position
Table 45. Lilly ICOS LLC Anti-erectile Dysfunction (ED) Drugs Models, Specifications and Application
Table 46. Lilly ICOS LLC Anti-erectile Dysfunction (ED) Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 47. Lilly ICOS LLC Company Profile and Main Business
Table 48. Lilly ICOS LLC Recent Developments
Table 49. Pfizer Company Information, Head Office, Market Area and Industry Position
Table 50. Pfizer Anti-erectile Dysfunction (ED) Drugs Models, Specifications and Application
Table 51. Pfizer Anti-erectile Dysfunction (ED) Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 52. Pfizer Company Profile and Main Business
Table 53. Pfizer Recent Developments
Table 54. Bayer Company Information, Head Office, Market Area and Industry Position
Table 55. Bayer Anti-erectile Dysfunction (ED) Drugs Models, Specifications and Application
Table 56. Bayer Anti-erectile Dysfunction (ED) Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 57. Bayer Company Profile and Main Business
Table 58. Bayer Recent Developments
Table 59. Hims Company Information, Head Office, Market Area and Industry Position
Table 60. Hims Anti-erectile Dysfunction (ED) Drugs Models, Specifications and Application
Table 61. Hims Anti-erectile Dysfunction (ED) Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 62. Hims Company Profile and Main Business
Table 63. Hims Recent Developments
Table 64. Menarini Group Company Information, Head Office, Market Area and Industry Position
Table 65. Menarini Group Anti-erectile Dysfunction (ED) Drugs Models, Specifications and Application
Table 66. Menarini Group Anti-erectile Dysfunction (ED) Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 67. Menarini Group Company Profile and Main Business
Table 68. Menarini Group Recent Developments
Table 69. Lupin Company Information, Head Office, Market Area and Industry Position
Table 70. Lupin Anti-erectile Dysfunction (ED) Drugs Models, Specifications and Application
Table 71. Lupin Anti-erectile Dysfunction (ED) Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 72. Lupin Company Profile and Main Business
Table 73. Lupin Recent Developments
Table 74. Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Company Information, Head Office, Market Area and Industry Position
Table 75. Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Anti-erectile Dysfunction (ED) Drugs Models, Specifications and Application
Table 76. Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Anti-erectile Dysfunction (ED) Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 77. Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Company Profile and Main Business
Table 78. Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Recent Developments
Table 79. General Factory Company Information, Head Office, Market Area and Industry Position
Table 80. General Factory Anti-erectile Dysfunction (ED) Drugs Models, Specifications and Application
Table 81. General Factory Anti-erectile Dysfunction (ED) Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 82. General Factory Company Profile and Main Business
Table 83. General Factory Recent Developments
Table 84. CSBio Company Information, Head Office, Market Area and Industry Position
Table 85. CSBio Anti-erectile Dysfunction (ED) Drugs Models, Specifications and Application
Table 86. CSBio Anti-erectile Dysfunction (ED) Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 87. CSBio Company Profile and Main Business
Table 88. CSBio Recent Developments
Table 89. Dong-A ST Company Information, Head Office, Market Area and Industry Position
Table 90. Dong-A ST Anti-erectile Dysfunction (ED) Drugs Models, Specifications and Application
Table 91. Dong-A ST Anti-erectile Dysfunction (ED) Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 92. Dong-A ST Company Profile and Main Business
Table 93. Dong-A ST Recent Developments
Table 94. Metuchen Pharma Company Information, Head Office, Market Area and Industry Position
Table 95. Metuchen Pharma Anti-erectile Dysfunction (ED) Drugs Models, Specifications and Application
Table 96. Metuchen Pharma Anti-erectile Dysfunction (ED) Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 97. Metuchen Pharma Company Profile and Main Business
Table 98. Metuchen Pharma Recent Developments
Table 99. Seoul Pharma Company Information, Head Office, Market Area and Industry Position
Table 100. Seoul Pharma Anti-erectile Dysfunction (ED) Drugs Models, Specifications and Application
Table 101. Seoul Pharma Anti-erectile Dysfunction (ED) Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 102. Seoul Pharma Company Profile and Main Business
Table 103. Seoul Pharma Recent Developments
Table 104. Teva Pharma Company Information, Head Office, Market Area and Industry Position
Table 105. Teva Pharma Anti-erectile Dysfunction (ED) Drugs Models, Specifications and Application
Table 106. Teva Pharma Anti-erectile Dysfunction (ED) Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 107. Teva Pharma Company Profile and Main Business
Table 108. Teva Pharma Recent Developments
Table 109. S.K. Chemicals Company Information, Head Office, Market Area and Industry Position
Table 110. S.K. Chemicals Anti-erectile Dysfunction (ED) Drugs Models, Specifications and Application
Table 111. S.K. Chemicals Anti-erectile Dysfunction (ED) Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 112. S.K. Chemicals Company Profile and Main Business
Table 113. S.K. Chemicals Recent Developments
List of Figure
Figure 1. Anti-erectile Dysfunction (ED) Drugs Picture
Figure 2. By Revenue, Global Anti-erectile Dysfunction (ED) Drugs Market Size and Forecast, 2019-2030, US$ Million
Figure 3. By Sales Volume, Global Anti-erectile Dysfunction (ED) Drugs Market Size and Forecast, 2019-2030, (K Units)
Figure 4. Global Anti-erectile Dysfunction (ED) Drugs Price Trend, 2019-2030, (US$/Unit)
Figure 5. By Revenue, China Anti-erectile Dysfunction (ED) Drugs Market Size and Forecast, 2019-2030, US$ million
Figure 6. By Sales Volume, China Anti-erectile Dysfunction (ED) Drugs Market Size and Forecast, 2019-2030, (K Units)
Figure 7. China Anti-erectile Dysfunction (ED) Drugs Price Trend, 2019-2030 (US$/Unit)
Figure 8. By Revenue, China Anti-erectile Dysfunction (ED) Drugs Share of Global Market, 2019-2030
Figure 9. By Sales Volume, China Anti-erectile Dysfunction (ED) Drugs Share of Global Market, 2019-2030
Figure 10. Global Anti-erectile Dysfunction (ED) Drugs Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 11. Global Anti-erectile Dysfunction (ED) Drugs Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2022
Figure 12. China Anti-erectile Dysfunction (ED) Drugs Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 13. China Anti-erectile Dysfunction (ED) Drugs Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 14. China Anti-erectile Dysfunction (ED) Drugs Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2019-2024
Figure 15. Chinese Local Players, Proportion of Anti-erectile Dysfunction (ED) Drugs Domestic VS Export, 2022
Figure 16. Global Anti-erectile Dysfunction (ED) Drugs Capacity, Production and Capacity Utilization, 2019-2030
Figure 17. Global Anti-erectile Dysfunction (ED) Drugs Capacity Market Share by Region, 2022 VS 2029
Figure 18. Global Anti-erectile Dysfunction (ED) Drugs Production Market Share & Forecast by Region, 2019-2030
Figure 19. Anti-erectile Dysfunction (ED) Drugs Industry Chain
Figure 20. Anti-erectile Dysfunction (ED) Drugs Procurement Model
Figure 21. Anti-erectile Dysfunction (ED) Drugs Sales Model
Figure 22. Anti-erectile Dysfunction (ED) Drugs Sales Channels, Direct Sales and Distribution
Figure 23. Sildenafil (Viagra)
Figure 24. Vardenafil (Levitra, Staxyn)
Figure 25. Tadalafil (Cialis)
Figure 26. Avanafil (Stendra)
Figure 27. Udenafil (Zydena)
Figure 28. Others
Figure 29. By Type, Global Anti-erectile Dysfunction (ED) Drugs Revenue, 2019-2030, US$ Million
Figure 30. By Type, Global Anti-erectile Dysfunction (ED) Drugs Revenue Market Share, 2019-2030
Figure 31. By Type, Global Anti-erectile Dysfunction (ED) Drugs Sales Volume, 2019-2030, (K Units)
Figure 32. By Type, Global Anti-erectile Dysfunction (ED) Drugs Sales Volume Market Share, 2019-2030
Figure 33. By Type, Global Anti-erectile Dysfunction (ED) Drugs Price, 2019-2030, (US$/Unit)
Figure 34. Hospital
Figure 35. Retail Pharmacy
Figure 36. Clinic
Figure 37. Online Pharmacy
Figure 38. By Application, Global Anti-erectile Dysfunction (ED) Drugs Revenue, 2019-2030, US$ Million
Figure 39. By Application, Global Anti-erectile Dysfunction (ED) Drugs Revenue Market Share, 2019-2030
Figure 40. By Application, Global Anti-erectile Dysfunction (ED) Drugs Sales Volume, 2019-2030, (K Units)
Figure 41. By Application, Global Anti-erectile Dysfunction (ED) Drugs Sales Volume Market Share, 2019-2030
Figure 42. By Application, Global Anti-erectile Dysfunction (ED) Drugs Price, 2019-2030, (US$/Unit)
Figure 43. By Region, Global Anti-erectile Dysfunction (ED) Drugs Revenue Market Share, 2019-2030
Figure 44. By Region, Global Anti-erectile Dysfunction (ED) Drugs Sales Volume Market Share, 2019-2030
Figure 45. North America Anti-erectile Dysfunction (ED) Drugs Revenue & Forecasts, 2019-2030, US$ Million
Figure 46. By Country, North America Anti-erectile Dysfunction (ED) Drugs Revenue Market Share, 2022
Figure 47. Europe Anti-erectile Dysfunction (ED) Drugs Revenue & Forecasts, 2019-2030, US$ Million
Figure 48. By Country, Europe Anti-erectile Dysfunction (ED) Drugs Revenue Market Share, 2022
Figure 49. Asia Pacific Anti-erectile Dysfunction (ED) Drugs Revenue & Forecasts, 2019-2030, US$ Million
Figure 50. By Country/Region, Asia Pacific Anti-erectile Dysfunction (ED) Drugs Revenue Market Share, 2022
Figure 51. South America Anti-erectile Dysfunction (ED) Drugs Revenue & Forecasts, 2019-2030, US$ Million
Figure 52. By Country, South America Anti-erectile Dysfunction (ED) Drugs Revenue Market Share, 2022
Figure 53. Middle East & Africa Anti-erectile Dysfunction (ED) Drugs Revenue & Forecasts, 2019-2030, US$ Million
Figure 54. U.S. Anti-erectile Dysfunction (ED) Drugs Sales Volume, 2019-2030, (K Units)
Figure 55. By Company, U.S. Anti-erectile Dysfunction (ED) Drugs Market Share, 2022
Figure 56. By Type, U.S. Anti-erectile Dysfunction (ED) Drugs Sales Volume Market Share, 2022 VS 2029
Figure 57. By Application, U.S. Anti-erectile Dysfunction (ED) Drugs Sales Volume Market Share, 2022 VS 2029
Figure 58. Europe Anti-erectile Dysfunction (ED) Drugs Sales Volume, 2019-2030, (K Units)
Figure 59. By Company, Europe Anti-erectile Dysfunction (ED) Drugs Market Share, 2022
Figure 60. By Type, Europe Anti-erectile Dysfunction (ED) Drugs Sales Volume Market Share, 2022 VS 2029
Figure 61. By Application, Europe Anti-erectile Dysfunction (ED) Drugs Sales Volume Market Share, 2022 VS 2029
Figure 62. China Anti-erectile Dysfunction (ED) Drugs Sales Volume, 2019-2030, (K Units)
Figure 63. By Company, China Anti-erectile Dysfunction (ED) Drugs Market Share, 2022
Figure 64. By Type, China Anti-erectile Dysfunction (ED) Drugs Sales Volume Market Share, 2022 VS 2029
Figure 65. By Application, China Anti-erectile Dysfunction (ED) Drugs Sales Volume Market Share, 2022 VS 2029
Figure 66. Japan Anti-erectile Dysfunction (ED) Drugs Sales Volume, 2019-2030, (K Units)
Figure 67. By Company, Japan Anti-erectile Dysfunction (ED) Drugs Market Share, 2022
Figure 68. By Type, Japan Anti-erectile Dysfunction (ED) Drugs Sales Volume Market Share, 2022 VS 2029
Figure 69. By Application, Japan Anti-erectile Dysfunction (ED) Drugs Sales Volume Market Share, 2022 VS 2029
Figure 70. South Korea Anti-erectile Dysfunction (ED) Drugs Sales Volume, 2019-2030, (K Units)
Figure 71. By Company, South Korea Anti-erectile Dysfunction (ED) Drugs Market Share, 2022
Figure 72. By Type, South Korea Anti-erectile Dysfunction (ED) Drugs Sales Volume Market Share, 2022 VS 2029
Figure 73. By Application, South Korea Anti-erectile Dysfunction (ED) Drugs Sales Volume Market Share, 2022 VS 2029
Figure 74. Southeast Asia Anti-erectile Dysfunction (ED) Drugs Sales Volume, 2019-2030, (K Units)
Figure 75. By Company, Southeast Asia Anti-erectile Dysfunction (ED) Drugs Market Share, 2022
Figure 76. By Type, Southeast Asia Anti-erectile Dysfunction (ED) Drugs Sales Volume Market Share, 2022 VS 2029
Figure 77. By Application, Southeast Asia Anti-erectile Dysfunction (ED) Drugs Sales Volume Market Share, 2022 VS 2029
Figure 78. India Anti-erectile Dysfunction (ED) Drugs Sales Volume, 2019-2030, (K Units)
Figure 79. By Company, India Anti-erectile Dysfunction (ED) Drugs Market Share, 2022
Figure 80. By Type, India Anti-erectile Dysfunction (ED) Drugs Sales Volume Market Share, 2022 VS 2029
Figure 81. By Application, India Anti-erectile Dysfunction (ED) Drugs Sales Volume Market Share, 2022 VS 2029
Figure 82. Middle East & Asia Anti-erectile Dysfunction (ED) Drugs Sales Volume, 2019-2030, (K Units)
Figure 83. By Company, Middle East & Asia Anti-erectile Dysfunction (ED) Drugs Market Share, 2022
Figure 84. By Type, Middle East & Asia Anti-erectile Dysfunction (ED) Drugs Sales Volume Market Share, 2022 VS 2029
Figure 85. By Application, Middle East & Asia Anti-erectile Dysfunction (ED) Drugs Sales Volume Market Share, 2022 VS 2029
Figure 86. Research Methodology
Figure 87. Breakdown of Primary Interviews
Figure 88. Bottom-up Approaches
Figure 89. Top-down Approaches
Methodology/Research Approach
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Research Programs/Design
Historical Data (2015-2019) |
|
|
Influencing Factors |
|
|
Market Forecast (2021-2026) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).
The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report
The following figure shows an illustrative representation of the overall market size estimation process used for this study.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Data Source
Secondary Sources
Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
Market Size |
|
|
Market Position of Top Company |
|
|
Qualitative Analysis |
|
|
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.
Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
Key Executives Interviewed
Key Data Information from Primary Sources
Primary Sources | Parameters | Key Data |
Market Segments(by Application, by Type) |
|
|
Total Market |
|
|